Search clinical trials for: proteasome inhibitor
Total 67805 results
-
Odense University HospitalAarhus University Hospital; University of Southern Denmark; Sygehus LillebaeltRecruitingChemotherapy-induced Peripheral NeuropathyDenmark
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Taiwan, Spain, Australia, Brazil, France, United Kingdom, Poland, Singapore, Italy
-
University of ChicagoRecruitingKidney Transplantation | End Stage Kidney Disease (ESRD)United States
-
Hellenic Society of HematologySanofiNot yet recruitingNeoplasms | Neoplasms by Histologic Type | Hematologic Diseases | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Renal ImpairmentGreece
-
H. Lee Moffitt Cancer Center and Research InstituteAdaptive BiotechnologiesRecruitingMultiple MyelomaUnited States
-
National Cancer Institute (NCI)Janssen Scientific Affairs, LLCRecruiting
-
Martin SchrappeDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingAcute Lymphoblastic Leukemia, PediatricSwitzerland, Czechia, Israel, Italy, Germany, Australia, Austria, Slovakia
-
National Cancer Institute (NCI)RecruitingNeoplasms | Myelodysplastic Syndromes | LymphomasUnited States
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States
-
Tianjin Medical University General HospitalCompletedNeuromyelitis Optica Spectrum DisorderChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
PrECOG, LLC.TakedaCompletedMantle-Cell LymphomaUnited States
-
Janssen-Cilag Ltd.Legend BiotechCompletedMultiple MyelomaBelgium, United States, United Kingdom, Italy, Germany, Netherlands, Spain, France, Russian Federation, Poland
-
SCRI Development Innovations, LLCAmgenCompletedNeuroendocrine CancerUnited States
-
OncotherapeuticsAmgenTerminatedMultiple MyelomaUnited States
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
Fondazione EMN Italy OnlusActive, not recruitingMultiple Myeloma | New Diagnosis TumorItaly
-
Raija SilvennoinenBristol-Myers Squibb; Amgen; Hospital District of Helsinki and UusimaaCompletedMultiple Myeloma in RelapseFinland, Sweden
-
H Scott BoswellTakedaTerminatedAML | AML, AdultUnited States
-
University of NebraskaM.D. Anderson Cancer CenterTerminatedCabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple MyelomaMultiple Myeloma | Refractory Multiple Myeloma | Relapsed/Refractory Multiple MyelomaUnited States
-
Sara V. LatorreInstituto de Salud Carlos III; Fondos ARI (Assistencia Recerca Intensiva); Fondo...Active, not recruiting
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, France, Korea, Republic of, Canada, Belgium, New Zealand, Russian Federation
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple MyelomaUnited States, New Zealand
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationActive, not recruitingPlasma Cell Myeloma | Residual DiseaseUnited States
-
AmgenTerminated
-
TakedaCompleted
-
Johnson & Johnson Private LimitedCompleted
-
National Cancer Institute (NCI)TerminatedEpendymoma | Anaplastic Ependymoma | EpendymomasUnited States
-
CelgeneTriphaseCompletedGlioblastoma | Malignant GliomaUnited States, Canada
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNetherlands, Belgium, Germany, Spain, Czechia, Greece, Italy, Denmark, Serbia, Turkey
-
University of ArkansasMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
CelgeneTriphaseCompletedGlioblastoma | Malignant GliomaUnited States, Canada, Switzerland
-
Array Biopharma, now a wholly owned subsidiary...CompletedMultiple Myeloma, Plasma Cell LeukemiaUnited States
-
Assistance Publique - Hôpitaux de ParisFondation CentaureCompletedChronic Antibody-mediated Transplant RejectionFrance
-
PfizerCompletedAdvanced Multiple MyelomaUnited States
-
AmgenTerminatedMultiple MyelomaUnited States, France
-
National Cancer Institute (NCI)WithdrawnMultiple Myeloma
-
University of Wisconsin, MadisonMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.CompletedCarcinoma, Non Small Cell Lung
-
National Cancer Institute (NCI)Millennium Pharmaceuticals, Inc.Withdrawn
-
Charite University, Berlin, GermanyNeuroCure Clinical Research Center, Charite, Berlin; Prof. Dr. med. Falk Hiepe...TerminatedRheumatoid Arthritis | Systemic Lupus Erythematosus | Myasthenia GravisGermany
-
CelgeneCompleted
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and Refractory Multiple MyelomaUnited States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Steven E. CoutreNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
University Hospital, EssenUnknownEndothelial Dysfunction | Myeloma | Cardiooncology
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)Terminated
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States